Global Prenatal Testing Market Size, Share, Opportunities, And Trends By Technique (Non-Invasive (Sonography, Biochemical Screening Tests, Cell-Free DNA Screening Tests), Invasive (Amniocentesis, Chorionic Villus Sampling (CVS))), By Indication (Genetic Diseases, Infectious Diseases), By End Users (Hospitals And Clinics, Diagnostic Labs), And Geography - Forecasts From 2023 To 2028

The global prenatal testing market was valued at US$4.443 billion in 2021.

Prenatal tests are procedures that make sure that the mother and the fetus are healthy. Common prenatal testing includes ultrasound tests, amniocentesis, and chorionic villi sampling (CVS) tests. Growing healthcare expenditure and rising stress conditions due to the adoption of unhealthy living conditions are driving the growth of the global prenatal testing market in the forecast period. Currently, the focus is on non-invasive prenatal testing.

The demand for prenatal testing is also being fueled by the surge in the number of late pregnancies coupled with the rising demand for non-invasive procedures for early diagnosis of chromosomal disorders to help in the proper management of disease during the initial period of gestation. An increase in healthcare investments and growing awareness regarding prenatal testing will provide ample opportunities for growth for the market players during the given forecast period.

This research study examines the global prenatal testing market based on various segments: technique, indication, end-user, and geography. First, a brief overview of the market details key driving factors and challenges. Next, Porter's five forces model analyzes the prenatal testing industry comprehensively. This is followed by industry value chain analysis which determines the companies which are part of the different processes and contributing to various sectors.

The study also presents in-depth information concerning the development, trends, and industry policies and regulations affecting the global prenatal testing market. Moreover, the research study analyzes the overall regulatory framework of the prenatal testing sector, offering stakeholders a better understanding of the key factors influencing the overall market environment.

Global Prenatal Testing Market – Forecasts from 2023 to 2028 is a comprehensive and latest report. It provides vital market information to executives and interested stakeholders to enable them to get vital market information. The report also analyzes the competitive landscape and details strategies of key market players and also plots them on our vendor matrix in four quadrants: leader, follower, challenger, and niche.

The scope and coverage of the global prenatal testing market report is as below:

• Global prenatal testing market data tables and charts
• Market outlook with sections on drivers, restraints, Porter’s, and industry value chain analysis
• Market assessment by technique into non-invasive and invasive.
• Detailed market trends, analysis, and graphical representation by indication into genetic diseases and infectious diseases.
• In-depth analysis by end-users into hospitals and clinics, and diagnostic labs.
• A 360^o view of the demand for global prenatal testing market solutions/services across different geographies (North America, South America, Europe, Middle East and Africa, and Asia Pacific) with further breakdown for key countries within those regions.

Global Prenatal Testing Market Scope:

 

Report Metric	Details
Market Size Value in 2021	US$4.443 billion
Growth Rate	CAGR during the forecast period
Base Year	2021
Forecast Period	2023 – 2028
Forecast Unit (Value)	USD Billion
Segments Covered	Technique, Indication, End-User, and Geography
Regions Covered	North America, South America, Europe, Middle East and Africa, Asia Pacific
Companies Covered	Agilent Technologies, Inc., Invitae Corporation, Illumina, Inc., Laboratory Corporation of America® Holdings, Natera, Inc., Quest Diagnostics Incorporated, F. Hoffmann-La Roche Ltd, BGI Diagnosis Co., Ltd, IGENOMIX S.L.
Customization Scope	Free report customization with purchase

 

Different segments covered under the global prenatal testing market report are as below:

• By Technique
  • Non-invasive
    • Sonography
    • Biochemical Screening Tests
    • Cell-Free DNA Screening Tests
  • Invasive
    • Amniocentesis
    • Chorionic Villus Sampling (CVS) 
• By Indication
  • Genetic Diseases 
  • Infectious Diseases
• By End-User
  • Hospitals and Clinics
  • Diagnostic Labs
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • United Kingdom
    • Germany
    • France
    • Spain
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Israel
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Indonesia
    • Thailand
    • Others

1.  INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY  

2.1. Research Data

2.2. Assumptions

3. EXECUTIVE SUMMARY

3.1. Research Highlights

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Force Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

5. GLOBAL PRENATAL TESTING MARKET, BY TECHNIQUE

5.1. Introduction

5.2. Non-invasive

5.2.1. Sonography

5.2.2. Biochemical Screening Tests

5.2.3. Cell-Free DNA Screening Tests

5.3. Invasive

5.3.1. Amniocentesis

5.3.2. Chorionic Villus Sampling (CVS) 

6. GLOBAL PRENATAL TESTING MARKET, BY INDICATION

6.1. Introduction

6.2. Genetic Diseases 

6.3. Infectious Diseases

7. GLOBAL PRENATAL TESTING MARKET, BY END-USER

7.1. Introduction

7.2. Hospitals and Clinics

7.3. Diagnostic Labs

8. GLOBAL PRENATAL TESTING MARKET, BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. United States

8.2.2. Canada

8.2.3. Mexico

8.3. South America

8.3.1. Brazil

8.3.2. Argentina

8.3.3. Others

8.4. Europe

8.4.1. United Kingdom

8.4.2. Germany

8.4.3. France

8.4.4. Spain

8.4.5. Others

8.5. Middle East and Africa

8.5.1. Saudi Arabia

8.5.2. UAE

8.5.3. Israel

8.5.4. Others

8.6. Asia Pacific

8.6.1. Japan

8.6.2. China

8.6.3. India

8.6.4. South Korea

8.6.5. Indonesia

8.6.6. Thailand

8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Emerging Players and Market Lucrativeness

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Vendor Competitiveness Matrix

10. COMPANY PROFILES

10.1. Agilent Technologies, Inc.

10.2. Invitae Corporation

10.3. Illumina, Inc.

10.4. Laboratory Corporation of America® Holdings

10.5. Natera, Inc.

10.6. Quest Diagnostics Incorporated

10.7. F. Hoffmann-La Roche Ltd

10.8. BGI Diagnosis Co., Ltd

10.9. IGENOMIX S.L.

Agilent Technologies, Inc.

Invitae Corporation

Illumina, Inc.

Laboratory Corporation of America® Holdings

Natera, Inc.

Quest Diagnostics Incorporated

F. Hoffmann-La Roche Ltd

BGI Diagnosis Co., Ltd

IGENOMIX S.L.